Home›Stock Screener›Anlon Healthcare›Quarterly Results

Anlon Healthcare Quarterly Results

Latest Quarter Net Profit
₹11 Cr
QMar 2026
Quarterly Results

Anlon Healthcare quarterly results. In Mar 2026, Anlon Healthcare (AHCL) reported revenue ₹51 Cr and net profit ₹11 Cr — revenue +4.1% YoY. For annual financials, live price and key ratios, visit Anlon Healthcare share price screener.

AHCL Quarterly Results — Revenue, Profit & EPS Highlights

Anlon Healthcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review AHCL PE ratio trends to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹51 Cr in Mar 2026 (-42.0% vs Jun 2026, +4.1% vs Mar 2025)
  • Net Profit of ₹11 Cr in Mar 2026 (+37.5% vs Jun 2026, -35.3% vs Mar 2025)
  • EBITDA of ₹15 Cr in Mar 2026 (-6.2% vs Jun 2026)
  • Operating Margin of 30.0% in Mar 2026 (+12.0pp vs Jun 2026)
  • Earnings Per Share of ₹2.33 in Mar 2026 (+1356.2% vs Jun 2026)

Anlon Healthcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS

AHCL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 51 88 52 49 33 -42.0% 4.1%
Net Profit (₹ Cr) 11 8 9 17 4 - -
EBITDA (₹ Cr) 15 16 14 17 6 - -
EPS (₹) 2.33 0.16 1.75 5.15 0.89 - -
Operating Margin (%) 30.0% 18.0% 26.0% 35.0% 19.0% - -

AHCL Share Price Trend — 1-Year Movement Across Quarterly Results

Anlon Healthcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check AHCL company valuation to track the company's total market size over time.

Profitability Ratios

Profit Margin 21.6%
EBITDA Margin 29.4%
Operating Margin 30.0%
ROE (Annual) 17.3%

Balance Sheet Highlights

Total Assets ₹374 Cr
Total Equity ₹255 Cr
Current Assets ₹308 Cr
Current Liabilities ₹12 Cr

Cash Flow Analysis

Operating Cash Flow ₹-59 Cr
Investing Cash Flow ₹-36 Cr
Financing Cash Flow ₹118 Cr
Net Cash Flow ₹23 Cr

Current Market Data

Current Price ₹31.22
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 49
Sept 2025 52
Jun 2026 88
Mar 2026 51

Net Profit Trend (₹ Cr)

Mar 2025 17
Sept 2025 9
Jun 2026 8
Mar 2026 11

Operating Margin Trend (%)

Mar 2025 35.0%
Sept 2025 26.0%
Jun 2026 18.0%
Mar 2026 30.0%

AHCL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Anlon Healthcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Laurus Labs
Mar 2026 		₹109,629.35 Cr 1971.4 1,823 282 -10.5% - 15.5% 381.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores